Idexx Laboratories LPD — Cost of revenue decreased by 15.9% to $15.57M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.4%, from $14.23M to $15.57M. Over 3 years (FY 2022 to FY 2025), LPD — Cost of revenue shows an upward trend with a 10.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests margin compression due to rising production costs or supply chain inefficiencies, while a decrease suggests improved operational efficiency.
This metric captures the direct costs associated with producing and delivering diagnostic products and services within t...
Comparable to cost of goods sold (COGS) for specialized diagnostic or medical device segments in peer companies.
idxx_segment_lpd_cost_of_revenue| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.40M | $12.40M | $12.40M | $12.40M | $14.05M | $14.05M | $14.05M | $14.05M | $12.97M | $14.75M | $14.37M | $17.42M | $14.23M | $16.83M | $18.00M | $18.52M | $15.57M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +13.3% | +0.0% | +0.0% | +0.0% | -7.7% | +13.7% | -2.6% | +21.2% | -18.3% | +18.3% | +6.9% | +2.9% | -15.9% |
| YoY Change | — | — | — | — | +13.3% | +13.3% | +13.3% | +13.3% | -7.7% | +4.9% | +2.2% | +23.9% | +9.7% | +14.1% | +25.3% | +6.3% | +9.4% |